Modified Proteins

Patent No. EP2059527 (titled "Modified Proteins") was filed by Novo Nordisk Health Care on Sep 3, 2007. The application was issued on Dec 3, 2014.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
BAXALTASep 3, 2015HOFFMANN EITLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2059527

NOVO NORDISK HEALTH CARE
Application Number
EP07803166A
Filing Date
Sep 3, 2007
Status
Opposition Rejected
Nov 24, 2017
Publication Date
Dec 3, 2014